State-of-the-Art Quick Trim Clinic offers the latest weight loss combination to hit the market today
Heterogeneity of satellite cells implicates DELTA1/NOTCH2 signaling in self-renewal
Hold the syringe in place for a few seconds after the injection is complete, then remove the needle from your skin
May 15, 2025: Trulicity Shortage in Australia Continues While Federal Lawsuit in USA Moves Forward Global demand for drugs like Trulicity continues to deplete supplies
Almost all GLP-1 medications currently on the market are available only in an injectable form except for semaglutide, which is also available in an oral formulation (Rybelsus and oral Wegovy)
Private Plan Outlook Alberta Blue Cross's 2026 drug pipeline report identifies GLP-1 therapies as a major cost driver, stating that while a semaglutide generic is expected in mid-2026, overall GLP-1 therapy plan spend is unlikely to decline in future years due to growing use and continued expansion of GLP-1 therapies